When to Order Imaging for Evaluation of Cardiac Masses: ACR Appropriateness Decoded

When to Order Imaging for Evaluation of Cardiac Masses: ACR Appropriateness Decoded

A patient presents with new-onset heart failure, an embolic event, or an arrhythmia. An incidental finding on another study suggests an intracardiac structure. The differential for a cardiac mass is broad, ranging from benign thrombus and myxoma to primary sarcoma or metastasis. Choosing the right initial and follow-up imaging is critical for diagnosis, risk stratification, and surgical planning. The American College of Radiology (ACR) Appropriateness Criteria provide an evidence-based framework to guide this decision-making process, ensuring the most effective imaging modality is selected for each clinical scenario while minimizing unnecessary radiation exposure.

What Does ACR Evaluation of Cardiac Masses Cover?

This ACR guideline focuses on the diagnostic workup of suspected or known cardiac masses in adult patients. It addresses three primary clinical scenarios: the initial imaging for a suspected mass, the next steps after a mass is identified on echocardiography but its etiology is unknown, and follow-up imaging for a mass with an established diagnosis. The criteria are designed to help clinicians select the most appropriate imaging modality—including transthoracic and transesophageal echocardiography, cardiac magnetic resonance (CMR), cardiac computed tomography (CCT), and nuclear imaging—based on the specific clinical question. This guidance does not cover the evaluation of pericardial disease, valvular vegetations in the setting of endocarditis, or routine screening in asymptomatic patients. It is intended for situations where a discrete cardiac mass is a primary diagnostic consideration.

What Imaging Should I Order for Evaluation of Cardiac Masses? Recommendations by Clinical Scenario

The optimal imaging pathway for a cardiac mass depends on the clinical context, including whether it is an initial evaluation or a follow-up and what prior imaging has shown. The ACR provides specific recommendations for each situation.

For an adult with a suspected cardiac mass and no prior imaging, the ACR finds several options “Usually appropriate.” Transthoracic echocardiography (TTE) is a cornerstone for initial evaluation due to its accessibility, lack of radiation, and ability to assess cardiac function and morphology. For more detailed tissue characterization and anatomical definition, both MRI of the heart with and without IV contrast and CT of the heart with IV contrast are also rated “Usually appropriate.” MRI offers superior soft-tissue contrast, while CT can be valuable for assessing calcification and coronary anatomy. Transesophageal echocardiography (TEE), MRI without contrast, and CTA of the chest are considered “May be appropriate” but with panel disagreement, often reserved for cases where TTE is non-diagnostic or specific contraindications to other modalities exist.

When an adult has a known cardiac mass identified on echocardiography but the etiology is unknown, the goal shifts to definitive characterization. In this scenario, TEE, TTE, and cardiac MRI with and without contrast are all “Usually appropriate” to further define the mass’s features, location, and hemodynamic impact. Advanced imaging like FDG-PET/MRI, cardiac CT with contrast, and FDG-PET/CT are also “Usually appropriate” to assess metabolic activity, which can help differentiate benign from malignant etiologies and guide biopsy or surgical planning. An MRI without contrast may be appropriate in patients with severe renal dysfunction.

For an adult with a known cardiac mass of established etiology requiring follow-up, the imaging choice depends on the specific diagnosis and clinical question (e.g., assessing growth, response to therapy). TTE remains “Usually appropriate” for routine surveillance. Cardiac MRI, both with and without contrast, is also “Usually appropriate” for its excellent ability to track changes in size and tissue characteristics without ionizing radiation. FDG-PET/MRI and cardiac CT with contrast are also rated “Usually appropriate,” particularly for monitoring metabolically active or malignant tumors. TEE is “May be appropriate” if detailed valvular or atrial appendage assessment is needed.

ACR Imaging Recommendations Table

Adult vs. Pediatric Evaluation of Cardiac Masses Imaging: Radiation Dose Tradeoffs

While the ACR criteria for this topic are primarily focused on adults, the principles of imaging selection can be extrapolated to pediatric patients with important modifications, particularly concerning radiation dose. Children are inherently more radiosensitive than adults, and their longer life expectancy provides a greater window for potential long-term effects of radiation exposure to manifest. Therefore, the As Low As Reasonably Achievable (ALARA) principle is paramount. For pediatric patients, non-ionizing modalities like echocardiography and cardiac MRI are strongly preferred whenever they can provide the necessary diagnostic information. When CT is unavoidable, pediatric-specific protocols that reduce radiation dose are mandatory. The relative radiation level (RRL) footnotes in the ACR data reflect this, often showing a lower mSv range for pediatric CT scans compared to their adult counterparts. This underscores the critical need to weigh the diagnostic benefit of a radiation-based study against the cumulative dose and long-term risks in younger patients.

Imaging Protocol Details for Evaluation of Cardiac Masses

Once you have selected the most appropriate imaging study based on the clinical scenario, ensuring it is performed correctly is the next critical step. The diagnostic yield of cardiac MRI, CT, or advanced nuclear imaging studies is highly dependent on the specific imaging protocol, including contrast timing, sequence selection, and gating techniques. A well-designed protocol is essential to accurately characterize a mass, define its relationship to adjacent structures, and assess its hemodynamic consequences. For detailed guidance on technique and acquisition parameters for these complex studies, clinicians and technologists can refer to standardized institutional or society guidelines.

Tools to Help You Order the Right Study

Navigating imaging guidelines and patient-specific factors can be complex. GigHz offers several tools designed to support evidence-based clinical decision-making for physicians and trainees.

• ACR Appropriateness Criteria Lookup: For clinical questions beyond the evaluation of cardiac masses, this tool provides direct access to the full library of ACR guidelines, covering thousands of clinical variants across all organ systems.

• Imaging Protocol Library: After choosing the right study, access detailed, step-by-step protocols for a wide range of CT, MRI, and ultrasound examinations to ensure high-quality, consistent imaging.

• Radiation Dose Calculator: This tool helps you estimate and track cumulative radiation exposure for your patients. It is a valuable resource for counseling patients on the risks and benefits of imaging and for adhering to the ALARA principle.

Frequently Asked Questions about Imaging for Cardiac Masses

Answers to common clinical questions about selecting the right imaging test for a suspected or known cardiac mass.

Why is transthoracic echocardiography (TTE) often the first-line imaging test?

TTE is typically the initial imaging modality because it is non-invasive, widely available, cost-effective, and uses no ionizing radiation. It provides excellent real-time information about cardiac structure, function, and hemodynamics, making it an ideal first step to confirm the presence of a mass, assess its mobility, and evaluate its impact on heart function.

When is cardiac MRI (CMR) preferred over cardiac CT?

Cardiac MRI is generally preferred over CT for tissue characterization. Its superior soft-tissue contrast and ability to use various imaging sequences (e.g., T1/T2 weighting, late gadolinium enhancement) can help differentiate between thrombus, benign tumors like myxomas or fibromas, and malignant masses. It is also the preferred modality in younger patients and for follow-up imaging to avoid repeated radiation exposure.

In what situations is cardiac CT more useful than cardiac MRI?

Cardiac CT is more useful than MRI in several specific situations. It is superior for detecting calcification within a mass, which is a key feature of certain tumors. CT is also the modality of choice for patients with contraindications to MRI, such as incompatible pacemakers or defibrillators. Additionally, cardiac CT provides excellent simultaneous evaluation of the coronary arteries, which can be critical for pre-operative planning.

What is the role of PET/CT or PET/MRI in evaluating cardiac masses?

FDG-PET/CT and FDG-PET/MRI are functional imaging techniques that assess the metabolic activity of a mass. They are particularly valuable when malignancy is suspected. Malignant tumors and inflammatory processes typically show high metabolic activity (FDG avidity), which can help differentiate them from benign masses or thrombus. These studies are also used for staging known malignancies by detecting metastatic disease and for monitoring the response to cancer therapy.

Why is a chest radiograph listed as “Usually not appropriate”?

A standard chest radiograph has very low sensitivity and specificity for detecting and characterizing intracardiac masses. While a very large mass might cause a subtle change in the cardiac silhouette, it cannot provide the detailed anatomical information needed for diagnosis. Cross-sectional imaging like echocardiography, CT, or MRI is required for direct visualization and evaluation of the mass.

What does the ACR rating “May be appropriate (Disagreement)” signify?

This rating indicates that the expert panel had a notable division of opinion for that specific imaging procedure in the given clinical scenario. It suggests that the procedure may be a reasonable choice in certain circumstances, but its value is not as clearly established or universally agreed upon as a procedure rated “Usually appropriate.” The decision to use such a test often depends on local expertise, specific patient factors, or the results of initial, higher-rated imaging studies.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026